Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 1Metabolic Syndrome 1Inflammation 1Dyslipidemias 1

Interventions

semaglutide 1cytisine 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Topiramate 1Tirzepatide 1Surgical Procedures, Operative 1Spirometry 1Radiotherapy 1Qsymia 1Phentermine 1Naltrexone 1Mindfulness 1Liraglutide 1Hematologic Tests 1Glucagon-Like Peptide-1 Receptor 1Diethylpropion 1Diet Therapy 1Bupropion 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Inflammation × Naltrexone × Clear all
NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡